300639.SZ SHZ
Guangdong Hybribio Biotech Co.,Ltd.
1W: +2.4%
1M: +6.8%
3M: +21.8%
YTD: -13.8%
1Y: -6.1%
3Y: -42.1%
5Y: -50.8%
¥6.32 ($0.94)
+0.12 (+1.94%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥4.1B ($609.2M)
52W Range4.75-10.07
Volume14,343,895
Avg Volume15,206,329
Beta0.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJianyu Wang
Employees1,990
SectorHealthcare
IndustryMedical - Specialties
IPO Date2017-04-13
Websitehybribio.cn
D5-3-3-4, North High-tech Zone
Chaozhou, GD 521000
CN
Chaozhou, GD 521000
CN
852 2851 8029
About Guangdong Hybribio Biotech Co.,Ltd.
Guangdong Hybribio Biotech Co., Ltd. engages in the research, development, production, and sale of nucleic acid molecular diagnostic products in China. It also provides on-site technical training and after-sales technical service support. The company was founded by Qiao Zhong Guan on June 13, 2003 and is headquartered in Chaozhou, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found